HomeTHAR • NASDAQ
Tharimmune Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.55M | 8.49% |
Net income | -2.54M | -12.66% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.08M | -87.23% |
Total assets | 1.66M | -81.31% |
Total liabilities | 2.48M | 34.72% |
Total equity | -814.67K | — |
Shares outstanding | 2.66M | — |
Price to book | -3.38 | — |
Return on assets | -236.55% | — |
Return on capital | -1,665.74% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.54M | -12.66% |
Cash from operations | -2.69M | 4.82% |
Cash from investing | — | — |
Cash from financing | 205.57K | -35.18% |
Net change in cash | -2.48M | 0.98% |
Free cash flow | -2.23M | -29.48% |
Previous close
$1.32
Day range
$1.26 - $1.36
Year range
$0.95 - $6.28
Market cap
3.54M USD
Avg Volume
159.25K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2017
Headquarters
Website
Employees
2
